No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 pN0M0 prostate cancer

Journal of Urology

Volumn 168, Issue 3, 2002, Pages 1188-1192

  Fodstad, Philip ^a   Bjøro, Trine ^a   Torlakovic, Goran ^a   Fosså, Sophie D ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Pituitary hormones; Prognosis; Prostate; Prostatic neoplasms; Sex hormones

Indexed keywords

ESTRADIOL; FOLLITROPIN; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER STAGING; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS GONAD SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

EID: 0036717713     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64623-X     Document Type: Article

References (20)

1. What causes prostate cancer? A brief summary of the epidemiology
2. Prostate cancer in African-American men
3. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma
4. Carcinoma of the prostate: Relationship of pre-treatment hormone levels to survival
5. Is low serum free testosterone a marker for high grade prostate cancer?
6. Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients
7. High-grade prostate cancer is associated with low serum testosterone levels
8. Independent prognostic factors in patients with metastatic (stage D2) prostate cancer
9. Hormone refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR)
10. Coexpression of gonadotrophic hormones and their corresponding FSH- and LH/CG-receptors in the human prostate
11. Prognostic value of serum hormone concentration in prostatic cancer
12. Correlation of pretreatment plasma levels of estradiol and sex-hormone-binding-globulin-binding-capacity with clinical stage and survival of patients with prostatic cancer
13. Prognostic factors for clinically localized prostate carcinoma: Analysis of 938 patients irradiated in the prostate specific antigen era
14. Histological grading and clinical staging of prostate carcinoma
15. Prognostic significance of histologic grading in patients with prostate cancer who are assessed by the Gleason and World Health Organization grading system in needle biopsies obtained prior to radiotherapy
16. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia
17. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging
18. Modeling of circadian testosterone in healthy men and hypogonadal men
19. Serum testosterone - A significant determinant of metastatic relapse for irradiated localized prostate cancer
20. Advanced prostate cancer is associated with a decrease in serum luteinizing hormone